Global Wound Care Biologics Market is Growing at a Significant Rate in the Forecast Period 2018-2025

Global Wound Care Biologics Market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Access Full Report at

Segmentation: Global Wound Care Biologics Market

Global Wound Care Biologics Market, By Products Type (Synthetic Skin Grafts, Growth Factors, Allografts, Xenografts), Wound Type (Wounds, Ulcers, Burns), End User (Hospitals, Wound Care Centres, Ambulatory Centers,Clinics, Community Healthcare Center), Geography (Europe, North America, Asia-Pacific, South America, Middle East & Africa)– Industry Trends and Forecast to 2025

Drivers: Global Wound Care Biologics Market

Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, aging population, innovation in wound care biologics are fuel the growth of wound care biologics market.

Increasing  Cases of Diabetic Foot Ulcers:

The prevalence of diabetic foot ulcers has increased significantly over a period of time. Mentioned below are some of the important statistics related to diabetic foot ulcers:

  • According to National Centre for Biotechnology Information (NCBI), an article published in 2017 reports that prevalence of ulcers is higher in males 4.5% than in females 3.5%. It also reports that diabetic foot ulcers is more prevalent in type 2 diabetic patients 6.4% than type 1 diabetics 5.5%.
  • As per the Journal of Diabetes Research in 2017, approximately 13.6% patients suffered from diabetic foot ulcers.
  • According to the American Podiatric Medical Association, in 2016, approximately 14.0% to 24.0% Americans suffered from diabetic foot ulcers have amputations

Increasing Incidences of Burn Cases:

The rising incidences of burn injuries drive the demand of wound care products for curing the burn injuries. According to World Health Organization (WHO), the majority of burn cases occur in low- and middle-income countries and an estimated 180,000 deaths every year are caused by burns. Burn injuries occur mainly in the home and workplace due to lack of required infrastructure such as equipment, resources and personnel required to safe surgery which includes surgical equipment, blood oxygen, water and others. As per the American Burn Association in 2016, approximately 60.0% of the patient hospitalizations related to burn injury acute hospitalizations related to burn injury were admitted to 128 burn centers in U.S.

  • According to the American Burn Association in between 2011 to 2015, approximately 486,000 injuries reported in U.S.
  • According to Medical Journal of Australia in 2014 approximately 7184 peoples suffered from burn injuries in Australia.
  • According to the Australian Institute of Health and Welfare in between 2013 to 2014 approximately 5,430 cases of hospitalised burn injury were reported in Australia

Rising number of geriatric population:

  • As per the National Institutes of Health in 2015, Americans which is 65 and over age population is expected to double in next three decades, from 48 million to 88 million by 2015.
  • According to the World Health Organization in 2010, approximately 524 million were aging population which were 8.0% of the world population.
  • As per the Study of Population Reference Bureau, the number of Americans ages 65 and older is projected to more than double from 46 million today to over 98 million by 2060, and the 65-and-older age group’s share of the total population will rise to nearly 24 percent from 15 percent.

Major Players: Global Wound Care Biologics Market

Some of the prominent participants operating in this market are MiMedx, Organogenesis Inc. Integra Life Sciences, ConvaTec Inc., Acell Inc., Allsource, Alphatec Spine, Inc., Amnio Technology, LLC, Amniox Medical, Inc., Anika Therapeutics, Inc., BioHorizons IPH, Inc., Kerecis, Marine Polymer Technologies, Inc., Mölnlycke Health Care AB, Osiris Therapeutics, Inc., Skye Biologics Inc., Smith & Nephew, Solsys Medical, Vericel Corporation, Wright Medical Group N.V. among others.